Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for alogliptin

  1. Type 2 diabetes: alogliptin (ESNM20)

    This evidence summary has been updated and replaced by NICE guideline NG28.

    Evidence summary
    Published
    21 May 2013